Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 food-effect and single-/multiple-ascending-dose study of DF2755A in healthy participants
NL-OMON59561Phase 1Not yet recruiting
- Sponsor
- Dompé
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of df2755a in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS), sponsored by Dompé. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
df2755a
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on NL-OMON59561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59561.